Nu-Med Plus, Inc.
NUMD - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$798.72K
Close$
$-0.00
118.1% downside
Current Fair Value
118.1% downsideOvervalued by 118.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $798,723.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -2.11 |
| Outstanding Shares | 83,548,469 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -31.87 |
|---|---|
| PEG | 11.86 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nu-Med Plus, Inc.
2 employees
CEO: William R. Colvin
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such a...